United Therapeutics | UTHR - Interest Income

Stock Price
567.16
Daily Change
-5.69 -0.99%
Monthly
4.72%
Yearly
94.65%
Q2 Forecast
555.02

United Therapeutics reported $46.4M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Amarin USD 3.37M 3.37M Dec/2024
Baxter International USD 10M 4M Sep/2025
Bayer EUR 130M 38M Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Biogen USD 31.6M 700K Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.14 237M Mar/2026
Moderna USD 73M 8M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
United Therapeutics USD 46.4M 4.9M Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025